# Early-Stage Clinical Trial of AI-Driven CBCT-Guided Adaptive Radiotherapy for Lung Cancer

> **NIH NIH R21** · EMORY UNIVERSITY · 2024 · $195,556

## Abstract

According to NOT-OD-24-001, the parent abstract is at the beginning of the research strategy:
“The Research Strategy section should include a summary or abstract of the funded parent
award”

## Key facts

- **NIH application ID:** 11038651
- **Project number:** 3R21EB033994-02S1
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Aparna Kesarwala
- **Activity code:** R21 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $195,556
- **Award type:** 3
- **Project period:** 2023-05-01 → 2026-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11038651

## Citation

> US National Institutes of Health, RePORTER application 11038651, Early-Stage Clinical Trial of AI-Driven CBCT-Guided Adaptive Radiotherapy for Lung Cancer (3R21EB033994-02S1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/11038651. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*